Strides Pharma Science Ltd.
BSE: 532531 | Sector: Health care |
NSE: STAR | ISIN Code: INE939A01011 |
BSE 00:00 | 03 Feb | 296.50 |
-4.25 (-1.41%) |
OPEN
301.65 |
HIGH
304.30 |
LOW
294.80 |
NSE 00:00 | 03 Feb | 296.25 |
-5.25 (-1.74%) |
OPEN
303.00 |
HIGH
304.50 |
LOW
294.50 |
OPEN | 301.65 |
PREVIOUS CLOSE | 300.75 |
VOLUME | 13962 |
52-Week high | 413.50 |
52-Week low | 263.45 |
P/E | 18.75 |
Mkt Cap.(Rs cr) | 2,677 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Strides Pharma Science Ltd. (STAR) - Announcements
-
Strides Pharma Science Ltd Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Re
01/02/2023 | bse |
Downlaod PDF
-
Strides Pharma Science Ltd Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Re
01/02/2023 | bse |
Downlaod PDF
-
Strides Pharma Science Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
01/02/2023 | bse |
Downlaod PDF
-
Strides Pharma Science Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
25/01/2023 | bse |
Downlaod PDF
-
Strides Pharma Science Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
25/01/2023 | bse |
Downlaod PDF
-
Strides Pharma Science Ltd Grant Of Options Under Strides ESOP Plan 2016
24/01/2023 | bse |
Downlaod PDF
-
Strides Pharma Science Ltd Outcome Of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) For The Quarter A
24/01/2023 | bse |
Downlaod PDF
-
Strides Pharma Science Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
23/01/2023 | bse |
Downlaod PDF
-
Strides Pharma Science Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
20/01/2023 | bse |
Downlaod PDF
-
Strides Pharma Science Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
18/01/2023 | bse |
Downlaod PDF
-
Strides Pharma Science Ltd Board Meeting Intimation for Announcement Of Board Meeting Under Regulation 29 Of SEBI Listing Regul
17/01/2023 | bse |
Downlaod PDF
-
Strides Pharma Science Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
14/01/2023 | bse |
Downlaod PDF
-
Strides Pharma Science Ltd Notice Of Extraordinary General Meeting Of The Shareholders Of The Company Scheduled To Be Held On F
13/01/2023 | bse |
Downlaod PDF
-
Strides Pharma Science Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
28/12/2022 | bse |
Downlaod PDF
-
Strides Pharma Science Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
23/12/2022 | bse |
Downlaod PDF
-
Strides Pharma Science Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
22/12/2022 | bse |
Downlaod PDF
-
Strides Pharma Science Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
01/12/2022 | bse |
Downlaod PDF
-
Strides Pharma Science Ltd Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations A
28/11/2022 | bse |
Downlaod PDF
-
Strides Pharma Science Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
22/11/2022 | bse |
Downlaod PDF
-
Strides Pharma Science Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
18/11/2022 | bse |
Downlaod PDF
Quick Links for Strides Pharma Science:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices